About Us

Mission:  To promote the advancement of the science of biotherapeutics through quality based Good Manufacturing Practices

Development and manufacturing of therapeutic products represents a significant gap in bringing new therapeutics to the clinic and in commercialization of new products, however at the University of Minnesota, Molecular and Cellular Therapeutics has brought together the regulatory, quality, product development, manufacturing and facilities engineering expertise to enable the translation of novel, experimental research into medicine for use in human clinical trials. 

The complex and rigorous regulatory requirements, quality and technical expertise, and physical facilities needed for current Good Manufacturing Practices (cGMP) production of cell- and tissue-based products, monoclonal antibodies, and active pharmaceutical ingredients, --although outside the scope of most individual investigators and large institutions--have been brought together at Molecular and Cellular Therapeutics.  Our technical, development, regulatory, and quality expertise ensure that all FDA requirements are satisfied and products are delivered to the patient in the shortest possible time.


 MCT Org Chart 2020